http://www.chemanager-online.com/enen/rss.xml en http://www.chemanager-online.com/en/news-opinions/headlines/glaxosmithkline-hires-goldman-sachs-banker-new-chief-financial-officer Glaxosmithkline said on Wednesday it had hired Goldman Sachs investment banker Simon Dingemans to succeed Chief Financial Officer Julian Heslop, 59, who will retire next March. Dingemans has more than 25 years experience in investment banking and most recently led Goldman Sachs' european M&A business, Britain's largest drugmaker said. http://www.chemanager-online.com/en/news-opinions/headlines/glaxosmithkline-hires-goldman-sachs-banker-new-chief-financial-officer http://www.chemanager-online.com/en/news-opinions/headlines/thermo-fisher-scientific-adds-vialis-paperless-lab-solutions-its-global-part Thermo Fisher Scientific today announced that it has extended its reach across Central Europe by making Vialis the latest member of its informatics global partner alliance. Vialis, based in Switzerland, will provide local services and support for the full range of thermo scientific informatics solutions, including laboratory information management systems, chromatography data systems, electronic laboratory notebooks and spectroscopy software, as well as comprehensive laboratory automation and integration solutions. http://www.chemanager-online.com/en/news-opinions/headlines/thermo-fisher-scientific-adds-vialis-paperless-lab-solutions-its-global-part http://www.chemanager-online.com/en/news-opinions/headlines/merck-sees-fast-ruling-johnson-and-johnsons-remicade-arbitration Merck said an arbitration panel would look in late September at whether the company is entitled to overseas rights to Remicade and Simponi, Johnson & Johnson's important rheumatoid arthritis drugs. Merck has said it acquired those rights to the drugs with its $41 billion purchase of Schering-Plough Corp last November. In a regulatory filing, Merck said the arbitration involving blockbuster arthritis treatment Remicade and a potentially lucrative newer drug called Simponi would take place in New York and probably last no more than 12 business days. http://www.chemanager-online.com/en/news-opinions/headlines/merck-sees-fast-ruling-johnson-and-johnsons-remicade-arbitration http://www.chemanager-online.com/en/news-opinions/headlines/us-use-bp-cash-study-spill-health-effects The U.S. National Institutes of Health said on Tuesday it would use $10 million from BP to start a multiyear study to look at the potential health effects from the oil spill in the Gulf of Mexico. The NIH has already designated another $10 million to begin the study, which will look at the health effects on clean-up workers from oil and dispersants, including respiratory, neurobehavioral, carcinogenic, and immune conditions. The study will also include mental health concerns and other spill-related problems such as job loss, family disruption and financial uncertainty. http://www.chemanager-online.com/en/news-opinions/headlines/us-use-bp-cash-study-spill-health-effects http://www.chemanager-online.com/en/news-opinions/headlines/sanofi-ceo-meets-genzyme-holders-mulls-next-move Sanofi-Aventis Chief Executive Chris Viehbacher has stepped up his campaign to win Genzyme by meeting shareholders of the U.S. biotech company face to face, the French company said Tuesday. Genzyme last week rejected an all-cash $18.5 billion takeover offer from the French drugmaker, setting the stage for a potentially hostile takeover battle. But Viehbacher has made it clear he would rather get his opposite number, Henri Termeer, to the negotiating table and is keen to sound out investors before making his next move. http://www.chemanager-online.com/en/news-opinions/headlines/sanofi-ceo-meets-genzyme-holders-mulls-next-move http://www.chemanager-online.com/en/news-opinions/headlines/rio-tinto-russia-meet-uralkali Representatives of Rio Tinto have come to Russia to visit potash producer Uralkali which is seen as a potential acquisition target for the mining giant, Vedomosti reported on Wednesday. Rio Tinto, along with Potash, could buy into Uralkali as Russia seeks a full overhaul of the fertilisers industry, sources told press representatives last month, adding that talks were at an early stage. http://www.chemanager-online.com/en/news-opinions/headlines/rio-tinto-russia-meet-uralkali http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-buys-chinese-vehicle-refinish-supplier AkzoNobel is to significantly boost its presence in the Chinese automotive market after agreeing to acquire Changzhou Prime Automotive Paint. Financial details were not disclosed. Prime is one of China's largest vehicle refinish suppliers and a leader in the fast-growing mid-market segment. This sector is estimated to double in size within the next five years. Based in Jiangsu Province, the company develops, manufactures, markets and distributes automotive coatings, primarily for the refinish market. http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-buys-chinese-vehicle-refinish-supplier http://www.chemanager-online.com/en/products/dienstleistungen/coping-challenges-new-regulations REACH & CLP are forcing all companies putting chemical products on the EU market to recreate all SDS's according to the new REACH SDS format! For more than 20 years Atrion has supported large and small chemical manufacturing companies with a powerful rule-engine that automates SDS generation in 44 languages. The Atrion solution is used extensively within the formula-based process industry (paint, coatings and inks, adhesives, soap and detergents, fragrance & flavours, petrochemicals, etc.) but also supports other industry sectors worldwide. http://www.chemanager-online.com/en/products/dienstleistungen/coping-challenges-new-regulations http://www.chemanager-online.com/en/news-opinions/headlines/lonza-signs-manufacturing-deal-glaxosmithkline Swiss drugs industry supplier Lonza will manufacture a number of drug compounds for Britain's Glaxosmithkline, in a sign demand for the Swiss group's  products is recovering. Lonza said it would support the ongoing development of GSK's biopharmaceutical pipeline by supplying manufacturing capacity for five early stage monoclonal antibodies. Lonza will initially manufacture clinical trial batches of five compounds currently in Phase 1 and 2 for GSK, it said. The group did not give any financial details of the deal. http://www.chemanager-online.com/en/news-opinions/headlines/lonza-signs-manufacturing-deal-glaxosmithkline http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-expands-salt-production-and-enhances-environmental-footprint Akzonobel today inaugurates its new salt plant in Delfzijl, the Netherlands. This €25 million investment will officially be opened by Werner Fuhrmann, president of Akzonobel industrial chemicals. The expansion has been combined with the conversion to full scale production of mTA industry salt - also of the other salt plants in Delfzijl. mTA, a complex of iron and meso-Tartrate, is a unique biodegradable anti-caking agent for salt, enhancing the CO2 footprint of the chlorine industry. http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-expands-salt-production-and-enhances-environmental-footprint http://www.chemanager-online.com/en/news-opinions/headlines/eu-asks-basf-explain-genetically-modified-potato-found-sweden European Union authorities said on Monday they had asked BASF to explain how unapproved, genetically modified potatoes developed by the German chemical company were found growing in Sweden. The potatoes were discovered growing in a field of "Amflora" potatoes, another GM variety that was approved for cultivation in the EU in March. The new variety - known as "Amadea" - has not been authorised for cultivation in the EU, the bloc's executive European Commission said. http://www.chemanager-online.com/en/news-opinions/headlines/eu-asks-basf-explain-genetically-modified-potato-found-sweden http://www.chemanager-online.com/en/news-opinions/headlines/air-products-raises-offer-airgas-55-billion Air Products and Chemicals said on Monday it raised its bid for Airgas to $5.5 billion, the latest salvo in its hostile bid for the rival company. The new Air Products cash offer of $65.50 a share represents a 3% increase from its previous bid of $63.50. The company said the price would mark a premium of more than 50% to the Airgas closing price on Feb. 4, the day before the takeover drive began. Air Products had made a $60 a share bid for the company in February. http://www.chemanager-online.com/en/news-opinions/headlines/air-products-raises-offer-airgas-55-billion http://www.chemanager-online.com/en/news-opinions/headlines/solvay-invests-minority-stake-polyera Solvay announces today that it is investing $4 million in a minority stake in Polyera, a leading materials developer for the printed electronics market, based in Skokie, Illinois. Polyera develops and commercializes organic semiconductors and dielectrics for organic thin-film transistors (OTFT) and organic photovoltaics (OPV), enabling applications such as flexible display backplanes, printed RFID tags and printed solar panels. This investment is being made under Polyera's series b financing, in which its prior investors are participating. http://www.chemanager-online.com/en/news-opinions/headlines/solvay-invests-minority-stake-polyera http://www.chemanager-online.com/en/news-opinions/headlines/kemira-invests-25-milllion-china-plant Kemira establishes a manufacturing facility in Nanjing, China to enhance customer service in the growing Chinese water treatment markets. The investment is expected to be at €25 million. The facility will be a state of the art regional production hub for a range of specialty process chemicals serving all of Kemira's customer segments. http://www.chemanager-online.com/en/news-opinions/headlines/kemira-invests-25-milllion-china-plant http://www.chemanager-online.com/en/news-opinions/headlines/glaxosmithkline-head-says-no-plan-bid-genzyme Glaxosmithkline will not step in as a rival bidder for U.S. biotech Genzyme and take on Sanofi-Aventis, the British drugmaker's head of research and development told a French newspaper. "An offer by GlaxoSmithKline for Genzyme does not make sense. It is too expensive," Moncef Slaoui told Les Echos on the sidelines of the inauguration of a GSK research centre in France. Analysts have said it looked unlikely a white knight would emerge and start a bidding war that could force French drugmaker Sanofi to significantly raise its $18.5 billion non-binding offer to buy Genzyme. http://www.chemanager-online.com/en/news-opinions/headlines/glaxosmithkline-head-says-no-plan-bid-genzyme http://www.chemanager-online.com/en/news-opinions/headlines/gerd-loebbert-appointed-borealis-executive-vice-president-polyolefins Borealis announces the move of Gerd Löbbert from his current position as executive vice president for base chemicals to the position of executive vice president for polyolefins, effective Oct. 1. Lorenzo Delorenzi, currently executive vice president for polyolefins has decided to leave Borealis by the end of this year and return to Belgium to pursue other career opportunities. http://www.chemanager-online.com/en/news-opinions/headlines/gerd-loebbert-appointed-borealis-executive-vice-president-polyolefins http://www.chemanager-online.com/en/news-opinions/headlines/airliquid-signs-major-contract-3sun Air Liquide has just signed a major long-term contract with 3Sun to become the sole supplier of gases and services to the new company. 3Sun, a manufacturing joint venture using Sharp advanced triple-junction technology to produce solar panels in Sicily, Italy has recently been established by Enel Green Power, Sharp and STMicroelectronics. http://www.chemanager-online.com/en/news-opinions/headlines/airliquid-signs-major-contract-3sun http://www.chemanager-online.com/en/news-opinions/headlines/umicore-obtains-license-japan-science-and-technology-agency Umicore has signed a license agreement with Japan Science and Technology Agency expanding its technology offering to the nobel-prize winning asymmetric ketone hydrogenation technologies of professors Noyori and Ikariya. Under the license, Umicore is allowed to market Ruthenium diammine and diphosphine Ruthenium diammine catalysts on an industrial scale. http://www.chemanager-online.com/en/news-opinions/headlines/umicore-obtains-license-japan-science-and-technology-agency http://www.chemanager-online.com/en/news-opinions/headlines/carbogen-amcis-and-eirgen-pharma-announce-partnership Carbogen Amcis, a Switzerland-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company announced a new strategic collaboration with Eirgen Pharma, an Ireland-based company that specializes in the manufacturing of solid-dose high-potency products. The companies will work together to provide timely and flexible manufacturing of highly potent active ingredients and solid oral-dose products for the treatment of cancer. http://www.chemanager-online.com/en/news-opinions/headlines/carbogen-amcis-and-eirgen-pharma-announce-partnership http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-be-primary-paint-supplier-walmart AkzoNobel has been selected by Walmart to be the primary paint supplier for the retailer's US stores. The company will develop and manufacture a portfolio of interior and exterior paints for more than 3,500 Walmart stores nationwide. This agreement builds on the existing relationship with Walmart, the world's largest retailer, for paints in Puerto Rico and Canada, and with Liquid Nails adhesives in the U.S. http://www.chemanager-online.com/en/news-opinions/headlines/akzonobel-be-primary-paint-supplier-walmart http://www.chemanager-online.com/en/news-opinions/headlines/air-products-signs-contract-russian-petrochemical-company Air Products today announced a contract to supply Voronezhsintezkauchuk, part of Russia and Eastern Europe's leading petrochemical company Sibur, with a new on-site air separation unit (ASU). The ASU will have the capacity to produce up to 3,000m/hour of gaseous nitrogen when on-stream in 2012, plus up to 16,000m/hour of dry compressed air. In addition to providing Voronezhsintezkauchuk with all of its industrial gas requirements, Air Products will supply liquid product to the Russian market. http://www.chemanager-online.com/en/news-opinions/headlines/air-products-signs-contract-russian-petrochemical-company http://www.chemanager-online.com/en/news-opinions/headlines/sanofi-aventis-ready-raise-bid-if-genzyme-talks French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a person familiar with the matter. The person played down recent reports that Sanofi's board was split over whether to pursue the deal after Genzyme rejected its initial offer, the news agency said. http://www.chemanager-online.com/en/news-opinions/headlines/sanofi-aventis-ready-raise-bid-if-genzyme-talks http://www.chemanager-online.com/en/news-opinions/headlines/solvay-invests-hydrogen-fluoride-china-joint-venture Belgian drugs, chemicals and plastics maker Solvay said on Sunday it had decided to build a new hydrogen fluoride installation for a Chinese joint  venture. Solvay said it had come to the decision with its partner Sinochem Lantian to build the installation for the venture Lansol Fluorchem. Commercial electronic grade hydrogen fluoride of the new installation will be available by the end of this year, Solvay said in a statement. The product is used in the electronics industry, particularly for the production of photovoltaic cells. http://www.chemanager-online.com/en/news-opinions/headlines/solvay-invests-hydrogen-fluoride-china-joint-venture http://www.chemanager-online.com/en/news-opinions/headlines/clayton-dubilier-and-rice-announces-agreement-cvc-capital-partners-invest-un Clayton, Dubilier & Rice and CVC Capital Partners today announced a definitive agreement for CD&R to acquire a 42.5% ownership interest in Univar, a leading global distributor of commodity and specialty chemicals to a broad array of end markets. The transaction values the company at  approximately $4.2 billion. Funds advised by CVC will retain a 42.5% stake in the business. The remaining equity will be held by Univar management and other existing investors. http://www.chemanager-online.com/en/news-opinions/headlines/clayton-dubilier-and-rice-announces-agreement-cvc-capital-partners-invest-un http://www.chemanager-online.com/en/news-opinions/headlines/airgas-and-bae-systems-sign-five-year-supply-agreement Airgas today announced it has signed a strategic agreement with BAE Systems, the UK-based defense and aerospace company. Airgas will supply BAE System's manufacturing locations throughout the U.S. with bulk and packaged industrial gas, welding hardgoods and related products and personal protective equipment (PPE) products. The five-year agreement will be part of the Airgas strategic accounts program which serves multi-location customers who benefit from sole-source supply and supply chain management services. http://www.chemanager-online.com/en/news-opinions/headlines/airgas-and-bae-systems-sign-five-year-supply-agreement